Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin

doi:10.1084/jem.164.4.1043

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Williams, C. L.
	Articles by Lennon, V. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Williams, C. L.
	Articles by Lennon, V. A.


Social Bookmarking

	What's this?

ARTICLES

Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin

CL Williams and VA Lennon

Striational autoantibodies (StrAb), which react with elements of skeletal muscle cross-striations, occur frequently in patients with thymoma associated with myasthenia gravis (MG). Dissociated thymic lymphocytes from 22 of 72 MG patients secreted StrAb when cultured with PWM. A high yield of EBV-transformed B cell lines was established from thymus, thymoma, and peripheral blood of seven patients with MG, but clones secreting StrAb arose only from the three patients who had StrAb in their sera. The monoclonal StrAb bound to A bands or I bands in skeletal muscle of human, rat, and frog. One bound to mitochondria in addition to myofibrillar I bands. None bound to nuclei, smooth muscle, or gastric mucosal cells. In immunoblot analyses and ELISAs the monoclonal StrAb bound to muscle and nonmuscle isotypes of myosin, alpha actinin, and/or actin. All bound to contractile proteins common to thymus and muscle, and one selectively immunostained epithelial cells of the thymic medulla. From these antigenic specificities we suggest that StrAb might arise as an immune response directed against the cytoskeletal anchoring proteins associated with nicotinic acetylcholine receptors in thymic epithelial cells undergoing neoplastic transformation to thymoma.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Vernino, S., Lennon, V. A. (2004). Autoantibody Profiles and Neurological Correlations of Thymoma. Clin. Cancer Res. 10: 7270-7275 [Abstract] [Full Text]
Shiono, H., Wong, Y. L., Matthews, I., Liu, J.-L., Zhang, W., Sims, G., Meager, A., Beeson, D., Vincent, A., Willcox, N. (2003). Spontaneous production of anti-IFN-{alpha} and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor. Int Immunol 15: 903-913 [Abstract] [Full Text]
Buckley, C., Newsom-Davis, J., Willcox, N., Vincent, A. (2001). Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?. Neurology 57: 1579-1582 [Abstract] [Full Text]
Yamamoto, A. M., Gajdos, P., Eymard, B., Tranchant, C., Warter, J.-M., Gomez, L., Bourquin, C., Bach, J.-F., Garchon, H.-J. (2001). Anti-Titin Antibodies in Myasthenia Gravis: Tight Association With Thymoma and Heterogeneity of Nonthymoma Patients. Arch Neurol 58: 885-890 [Abstract] [Full Text]
Ansevin, C. F., Vernino, S., Harper, C. M., Auger, R. G., Lennon, V. A. (2000). Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 55: 458-459 [Full Text]
Mygland, A., Vincent, A., Newsom-Davis, J., Kaminski, H., Zorzato, F., Agius, M., Gilhus, N. E., Aarli, J. A. (2000). Autoantibodies in Thymoma-Associated Myasthenia Gravis With Myositis or Neuromyotonia. Arch Neurol 57: 527-531 [Abstract] [Full Text]
Strassheim, D., May, L. G., Varker, K. A., Puhl, H. L., Phelps, S. H., Porter, R. A., Aronstam, R. S., Noti, J. D., Williams, C. L. (1999). M3 Muscarinic Acetylcholine Receptors Regulate Cytoplasmic Myosin by a Process Involving RhoA and Requiring Conventional Protein Kinase C Isoforms. J. Biol. Chem. 274: 18675-18685 [Abstract] [Full Text]